BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12426322)

  • 1. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
    Stroschein SL; Bonni S; Wrana JL; Luo K
    Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
    Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
    J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1.
    Nourry C; Maksumova L; Pang M; Liu X; Wang T
    BMC Cell Biol; 2004 May; 5():20. PubMed ID: 15144564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.
    Bonni S; Wang HR; Causing CG; Kavsak P; Stroschein SL; Luo K; Wrana JL
    Nat Cell Biol; 2001 Jun; 3(6):587-95. PubMed ID: 11389444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction.
    Wan Y; Liu X; Kirschner MW
    Mol Cell; 2001 Nov; 8(5):1027-39. PubMed ID: 11741538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ; McGonigle S; Pearce EJ
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
    Nagarajan RP; Liu J; Chen Y
    J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.
    Nagano Y; Mavrakis KJ; Lee KL; Fujii T; Koinuma D; Sase H; Yuki K; Isogaya K; Saitoh M; Imamura T; Episkopou V; Miyazono K; Miyazawa K
    J Biol Chem; 2007 Jul; 282(28):20492-501. PubMed ID: 17510063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
    Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
    Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
    Levy L; Howell M; Das D; Harkin S; Episkopou V; Hill CS
    Mol Cell Biol; 2007 Sep; 27(17):6068-83. PubMed ID: 17591695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
    Vignais ML
    Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
    Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
    J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of specificity in TGF-beta signal transduction.
    Chen YG; Hata A; Lo RS; Wotton D; Shi Y; Pavletich N; Massagué J
    Genes Dev; 1998 Jul; 12(14):2144-52. PubMed ID: 9679059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.